Synthetic Gels
to Standardize
Patient-Derived Organoids

watch the overview
What
is QGel

QGel provides tunable synthetic extracellular matrices (ECMs) for in vitro cellular based studies. QGel disease models recapitulate desired key physiological features of the human body and support the culture of any cell type, including:

Freshly isolated patient cells • Patient-derived organoids • Cells from PDX · Cell lines

QGel cell based assays can be used for applications in:

Drug discovery • Clinical decision making

Benefits of synthetic ECMs:

Reproducible • Industrially scalable • Suitable for clinical decision making

 

Find out more
Working
with QGel

Order online

QGel has a range of cell specific ECMs ready to ship. Visit our webshop and browse by any number of filter options. Each product comes with easy to use protocols to ensure the seamless integration of assays into your labs.

Visit the webshop
or

ECM identification for any application

QGel has an extensive library of gels that differ in key biological, biophysical and biochemical characteristics. Our ECM screening process identifies which ECM and media conditions will best support the needs of your research.

Learn about our ECM ID Program

Our mission

At QGel, we are passionate about providing solutions for the discovery of next generation drugs and accelerating patient access to personalized medicine.

In pursuit of our mission, we design industry-grade synthetic extracellular matrices that better approximate the human situation.

Backed by evidence-based science, QGel’s technology empowers biotech, pharmaceutical companies and health care centers with biologically accurate disease models for applications in drug discovery and patient diagnostics.

Learn more about QGel
“Clinical applications will warrant a transition to more-defined and mechanically-dynamic matrices to fully exploit the potential of organoid technologies.“
Dutta, D., Heo, I., Clevers, H., Disease Modeling in Stem Cell-Derived 3D Organoid Systems. Trends in Molecular Medicine (2017)
“The full potential of organoids in research and therapy has remained unrealized, owing to the poorly defined animal-derived matrices in which they are grown.“
Gjorevski, N. et al., Designer matrices for intestinal stem cell and organoid culture. Nature (2016)
“Half of the secret of the cell lies outside the cell.“
Bissell MJ, Modelling Molecular Mechanisms of Breast Cancer and Invasion: Lessons from the Normal Gland. Biochemical Society transactions (2007)
“Scientists are starting to realize just how much a cell’s context matters.“
Bissell MJ, Abbott, A et al. Cell culture: Biology’s new dimension. Nature. (2003)
2019 March 30-April 3
AACR | Annual Meeting

Atlanta, Georgia

Will you be at the AACR Conference in Atlanta, Georgia?  Contact us below if you would like to meet someone from the QGel team

2019 August 25-27
Cell Symposia | Engineering Organoids and Organs

San Diego, California

Will you be at the Cell Symposia Conference in San Diego, California?  Contact us below if you would like to meet someone from the QGel team

2019 June 13-14
SELECTBIO | 3D-Culture, Organoids & Tox Screening Europe 2019

Rotterdam, The Netherlands

Will you be at the 3D-Culture, Organoids & Tox Screening Conference in Rotterdam, The Netherlands?  Contact us below if you would like to meet someone from the QGel team

2019 May 7-9
3D Tissue Models | Oncology

Boston, Massachusetts

Will you be at the 3D Tissue Models Oncology Summit in Boston, Massachusetts?  Contact us below if you would like to meet someone from the QGel team

2019 March 30
Functional Precision Medicine Summit

Atlanta, Georgia

Will you be at the Functional Precision Medicine Summit in Atlanta, Georgia?  Contact us below if you would like to meet someone from the QGel team

QGel
Contact us